1190400-10-2

Upstream product

• 1190400-09-9 3-(4-methoxybenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione 
• 70978-37-9 1-(azidomethyl)-4-methoxybenzene 
• 1190400-09-9 3-(4-methoxy-benzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7-diol 
• 824-94-2 p-methoxybenzyl chloride 
• 133992-53-7 5-amino-1-[(4-methoxyphenyl)methyl]-1,2,3-triazole-4-carboxamide 

Downstream Products

• 1438466-68-2 (S)-1-[3-(4-methoxy-benzyl)-5-(2,2,2-trifluoro-ethoxy)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl]-pyrrolidin-3-ol 
• 1438466-67-1 (S)-1-[5-Chloro-3-(4-methoxy-benzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl]-pyrrolidin-3-ol 

Relevant academic research and scientific papers

NOVEL TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

[1, 2, 3]TRIAZOLO [4, 5 -D] PYRIMIDINE DERIVATIVES AS AGONISTS OF THE CANNABINOID RECEPTOR 2 AGONISTS

The invention relates to a compound of formula (I) wherein A and R to R 3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A and R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.